Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA
Academic Article
Publication Date:
2019
abstract:
To determine the incidence of serious infections (SIs) among the spondyloarthropathy (SpA) patients from the "Gruppo Italiano per lo Studio delle Early Arthritis" (GISEA) registry and treated with tumour necrosis factor (TNF) inhibitors (TNFIs), and to identify the factors associated with the development of the infections.
Iris type:
14.a.1 Articolo su rivista
Keywords:
Adalimumab; Adult; Antirheumatic Agents; Etanercept; Female; Humans; Infections; Infliximab; Italy; Male; Middle Aged; Registries; Spondylarthropathies; Surveys and Questionnaires; Tumor Necrosis Factor-alpha
List of contributors:
Atzeni, Fabiola; Sarzi-Puttini, Piercarlo; Sebastiani, Marco; Panetta, Valentina; Salaffi, Fausto; Iannone, Florenzo; Carletto, Antonio; Foti, Rosario; Gremese, Elisa; Govoni, Marcello; Marchesoni, Antonio; Favalli, Ennio; Gorla, Roberto; Ramonda, Roberta; Ferraccioli, Gianfranco; Lapadula, Giovanni
Published in: